Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venofer high-dose rapid infusion in iron deficiency
NCT02977611Phase 2Withdrawn
- Sponsor
- Guthrie
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iron sucrose in iron deficiency anemia (IDA), sponsored by Guthrie. Planned start Jan 2017; status: withdrawn.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02977611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02977611.